Guardant Health (GH) Current Deferred Revenue (2017 - 2026)

Guardant Health has disclosed Current Deferred Revenue across 10 years of filings, most recently posting $52.0 million for Q2 2026.

• In Q2 2026, Current Deferred Revenue fell 14.33% year-over-year to $52.0 million; the TTM figure through Jun 2026 stood at $52.0 million (down 14.33% YoY), while the FY2025 annual figure was $59.7 million, up 43.51% from the prior year.
• Current Deferred Revenue came in at $52.0 million for Q2 2026 at Guardant Health, down from $56.7 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $60.7 million in Q2 2025 to a low of $10.6 million in Q1 2022.
• Average Current Deferred Revenue over 5 years is $33.9 million, with a median of $30.2 million recorded in 2024.
• Year-over-year, Current Deferred Revenue jumped 134.44% in 2024 and dropped 14.33% in 2026.
• Over 5 years, Current Deferred Revenue stood at $21.2 million in 2022, then climbed by 8.02% to $22.9 million in 2023, then soared by 81.66% to $41.6 million in 2024, then jumped by 43.51% to $59.7 million in 2025, then decreased by 12.9% to $52.0 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $52.0 million in Q2 2026, $56.7 million in Q1 2026, and $59.7 million in Q4 2025.